Transcatheter arterial embolization with Nexsphere-Fâ„¢ was used to address a variety of joint disorders, including knee osteoarthritis, frozen shoulders, symptomatic rotator cuff tears ...
It is the only product approved under the European CE-MDD for musculoskeletal pain embolization and has recently launched in key European markets. "Nexsphere-Fâ„¢ has already been effectively used ...
SEOUL, South Korea, March 17, 2025 /PRNewswire/ -- NEXTBIOMEDICAL CO., LDT, announced that clinical study results of Nexsphere-Fâ„¢, a resorbable embolic agent for treating joint pain, have been ...